Core Laboratories (CLB) reported Q4 EPS of $0.14, $0.05 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $127.58 million versus the consensus estimate...
Investing.com - Core Laboratories (NYSE: CLB) reported fourth quarter EPS of $0.14, $0.05 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $127.58M...
As some of you know, my options portfolio is quite simple: an octet of puts, ranging in expiration from June to next January, anchored to the eight equities below which are: Core...
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.
|Average||23.50 (+15.93% Upside)|
|No. of Analysts||9|
|Moving Averages||Sell||Sell||Strong Sell||Strong Sell||Strong Sell|
|Technical Indicators||Strong Sell||Strong Sell||Strong Sell||Strong Sell||Sell|
|Summary||Strong Sell||Strong Sell||Strong Sell||Strong Sell||Strong Sell|